LFLiza Figueiredo Felicori

Liza Figueiredo Felicori

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liza Figueiredo Felicori has a total of 215 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Glycoproteome of Loxosceles Venom Reveals an Expanded Landscape of Animal Toxins

    by Raniele S. Moreira, Bruno C. S. Silva, Dener E. Bortolini, Manuela C. E. Ferreira, Carlena T. N. de Reyes, Marcele N. Rocha, Milene B. Carvalho, Martin R. Larsen, Carlos Chávez-Olórtegui, Franck Molina, et al.

    Spider venoms of the genus Loxosceles constitute a complex mixture of bioactive proteins and peptides associated with the major clinical manifestations of loxoscelism. Although significant advances have been made in the proteomic characterization of these toxins, studies addressing post-translational modifications, particularly glycosylation, and their potential impact on venom properties remain scarce. Here, we investigated the occurrence and characteristics of N-glycosylation in the venoms of Loxosceles gaucho , Loxosceles intermedia , and Loxosceles laeta . Using two-dimensional electrophoresis combined with glycoprotein-specific staining and LC-MS/MS, we identified glycosylation in different proteins biologically relevant to envenomation, predominantly belonging to the phospholipase D family, with distinct profiles among the species analyzed. Bottom-up glycoproteomic analysis of crude venoms using Byonic and a customized sequence database identified 88 N-glycosylated peptide sequences, primarily associated with lyases and hydrolases. Extensive microheterogeneity was detected at individual glycosylation sites, with paucimannosidic structures predominating alongside oligomannose and hybrid/complex N-glycans. Complementary enzyme-linked lectin assays supported the presence of distinct carbohydrate epitopes, including mannose, galactose, and N-acetylgalactosamine containing structures, and revealed α2,6-sialic acid-reactive motifs in two species. These findings establish N-glycosylation as an additional layer of molecular heterogeneity in Loxosceles venoms and provide a foundation for investigating its potential contribution to toxin properties and venom diversity.

  • Open Access

    Identification of gene conversion events in horse IGHV suggests preferential hotspots for diversification

    by Juliana Edelvacy Lima Pinto, João Henrique Brandão Gervásio, Joseph Chi-Fung Ng, Adriano Gomes-Silva, Herbert L. de Matos Guedes, Luiz Cunha, Leda R. Castilho, Jerson Lima da Silva, Glória Regina Franco, Carlena Navas, et al.

    The humoral immune response relies on a diverse antibody repertoire, which is expanded through processes such as somatic hypermutation, class-switch recombination and gene conversion. These processes are primarily mediated by activation-induced cytidine deaminase (AID). Gene conversion generates diversity in immunoglobulin heavy and light chains (IGHVs) in species such as chickens and rabbits, though it has not been widely studied. Since 80% of the equine IGHV repertoire originates from only three functional gene segments, we examined gene conversion events in horses to assess their role in antibody diversification. Using a modified version of BrepConvert, which optimized analysis time, we identified gene conversion events in 6.9% of immunoglobulin sequences. The results showed a local preference, with most events occurring at the beginning of framework region 1 (FR1) and within complementarity-determining region 2 (CDR2). Pseudogenes IGHV4-35, IGHV4-53, and IGHV4-38 were utilized most frequently, while functional genes IGHV4-21, IGHV4-22, and IGHV4-29 exhibited the highest event frequencies. Interestingly, while most mismatched regions were only three nucleotides long, 91% of these events are flanked by specific sequences (six nucleotides at the 5′ end and one nucleotide at the 3′ end). Furthermore, functional pseudogene pairs often share identical leader regions of 5–26 nucleotides, suggesting expanded events. We also identified a potential association between these events and local non-B DNA conformations, as well as with the zinc finger protein ZNF691, which supports the involvement of DNA-binding factors. Together, these findings demonstrate that gene conversion significantly contributes to equine antibody diversity by targeting specific IGHV regions.

  • Pseudogenes podem ser peças-chave na diversidade de anticorpos de cavalos

    by Juliana Edelvacy Lima Pinto, João Henrique Diniz Brandão Gervásio, Joseph Chi-Fung Ng, Carlena Navas, Liza Figueiredo Felicori

    A resposta imune humoral depende de um repertório diversificado de anticorpos gerados pela recombinação somática de segmentos do gene da imunoglobulina (Ig) nos linfócitos B. Os anticorpos consistem tipicamente em duas cadeias leves (L) e duas cadeias pesadas (H) ligadas por pontes dissulfeto, cada uma contendo regiões constantes (C) e variáveis (V). As regiões variáveis geralmente são responsáveis por interações específicas com antígenos. Além da recombinação V(D)J, existem diferentes mecanismos que geram a diversidade dos anticorpos, como a hipermutação somática, a conversão gênica e a recombinação de troca de classe, que aumentam ainda mais a diversidade de anticorpos com a enzima citidina desaminase induzida por ativação (AID) desempenhando um papel central. Dentre esses processos, a conversão gênica é um dos menos estudados. Esse mecanismo depende da introdução de segmentos de pseudogenes em genes funcionais. Com o intuito de identificar eventos de conversão gênica no repertório de imunoglobulinas da região variável da cadeia pesada (IGHV) de cavalos, dados de sequenciamento de Ig podem ser utilizados na identificação desses eventos em larga escala. Esse tipo de estudo pode trazer uma nova perspectiva na atuação de pseudogenes como geradores de diversidade em anticorpos, além de promover um melhor entendimento da resposta imunológica equina.

  • In vivo biodistribution of Loxosceles intermedia venom in animal models with different pathological outcomes

    by Raniele da Silva Moreira, Luiz Octávio Pires, Laís Cardoso Cunha, Isabela Abalen Fiorini de Carvalho, Carlos Chávez-Olórtegui, João Carlos Minozzo, Marcele Neves Rocha, Valbert Nascimento Cardoso, Simone Odilia Antunes Fernandes, Liza Figueiredo Felicori

  • Characterization of the lambda light chain repertoire and non-coding regions of equine immunoglobulins using the EquCab3 genome

    by Glória Maria da Silva, Carlena Navas, Milene Barbosa Carvalho, Yala Sampaio, Marcele Neves Rocha, Adriano Gomes-Silva, Herbert L. de Matos Guedes, Luiz Cunha, Leda R. Castilho, Jerson Lima da Silva, et al.


  • Open Access

    Profile of the B cell receptor repertoire and antibody responses upon 17DD-YF vaccine boosting

    by Christina A. Martins, Milene Barbosa Carvalho, João Diniz Gervásio, Carlena Navas, Luciana Zuccherato, Marcele Rocha, Manuela Emiliano Ferreira, Camila Souza, Adriana de Souza Azevedo Soares, Brenda de Moura Dias, et al.

    Although the 17DD-YF vaccine is highly effective in conferring long-term immunity, recent studies suggest that booster doses may be necessary in endemic areas. In this study, we characterized the dynamics of the B cell repertoire following 17DD-YF booster vaccination and examined its impact on antibody kinetics. Using a combined approach of serological analysis and B cell receptor (BCR) sequencing, we investigated molecular features of the antibody response in four vaccinated individuals from a YFV-endemic region. Our results indicate that the booster induces a transient antibody response, with limited effect on the neutralization capacity against DENV1-4 and ZIKV. Notably, we observed a rapid clonal expansion of B cells within 14 days post-vaccination, predominantly involving IgA and IgG isotypes. However, this expansion was short-lived, with reduced magnitude and persistence of these lineages by day 28. Interestingly, some of the expanded lineages shared sequence similarity with previously characterized anti-DENV and anti-ZIKV antibodies, although further validation is required to assess their functional relevance and presence in circulating serum. Together, these findings highlight the transient nature and isotype composition of the antibody response following YFV revaccination and provide insights into the complex interplay between pre-existing immunity and recall responses in individuals living in endemic regions.


  • Open Access

    Immunosenescence profile is associated with increased susceptibility to severe COVID-19

    by Lucas Haniel Araujo Ventura, Lícia Torres, Giovanna Caliman Camatta, Jofer Zamame, Monique Macedo Coelho, Cecília Horta Ramalho-Pinto, João Gervazio, Felipe Caixeta, Leandro Nascimento, Mariana Almeida Oliveira, et al.

    In this study we tested the hypothesis that the immunosenescence profile could account for the disproportional susceptibility of the elderly to severe forms of COVID-19. The immunological profiles of volunteers residing in endemic and non-endemic areas for chronic infectious diseases were analyzed at early stage of SARS-CoV-2 infection. A unique signature of inflammatory plasma mediators was identified in COVID-19 volunteers when compared to individuals with other flu-like syndromes. COVID-19 severity correlated with high levels of inflammatory mediators; among them, CXCL9, a serum marker of aging. Patients who progressed to hospitalization displayed high frequencies of CD8 + and CD4 + T cells expressing exhaustion and senescence markers and showed reduced and more mature B cell repertoires, which are typical of senescence. They also had an acceleration of epigenetic age measured by DNA methylation. Therefore, severe COVID-19 correlated with phenotypic, functional, and epigenetic features of accelerated immunosenescence at onset of infection.

  • Open Access

    Dynamic changes in B cell subpopulations in response to triple-negative breast cancer development

    by Igor Visconte Gonçalves, Natália Pinheiro-Rosa, Lícia Torres, Mariana de Almeida Oliveira, Gabriela Rapozo Guimarães, Christiana da Silva Leite, José Miguel Ortega, Miriam Teresa Paz Lopes, Ana Maria Caetano Faria, Mariana Lima Boroni Martins, et al.

    Despite presenting a worse prognosis and being associated with highly aggressive tumors, triple-negative breast cancer (TNBC) is characterized by the higher frequency of tumor-infiltrating lymphocytes, which have been implicated in better overall survival and response to therapy. Though recent studies have reported the capacity of B lymphocytes to recognize overly-expressed normal proteins, and tumor-associated antigens, how tumor development potentially modifies B cell response is yet to be elucidated. Our findings reveal distinct effects of 4T1 and E0771 murine tumor development on B cells in secondary lymphoid organs. Notably, we observe a significant expansion of total B cells and plasma cells in the tumor-draining lymph nodes (tDLNs) as early as 7 days after tumor challenge in both murine models, whereas changes in the spleen are less pronounced. Surprisingly, within the tumor microenvironment (TME) of both models, we detect distinct B cell subpopulations, but tumor development does not appear to cause major alterations in their frequency over time. Furthermore, our investigation into B cell regulatory phenotypes highlights that the B10 Breg phenotype remains unaffected in the evaluated tissues. Most importantly, we identified an increase in CD19 + LAG-3 + cells in tDLNs of both murine models. Interestingly, although CD19 + LAG-3 + cells represent a minor subset of total B cells (< 3%) in all evaluated tissues, most of these cells exhibit elevated expression of IgD, suggesting that LAG-3 may serve as an activation marker for B cells. Corroborating with these findings, we detected distinct cell cycle and proliferation genes alongside LAG-3 analyzing scRNA-Seq data from a cohort of TNBC patients. More importantly, our study suggests that the presence of LAG-3 B cells in breast tumors could be associated with a good prognosis, as patients with higher levels of LAG-3 B cell transcripts had a longer progression-free interval (PFI). This novel insight could pave the way for targeted therapies that harness the unique properties of LAG-3 + B cells, potentially offering new avenues for improving patient outcomes in TNBC. Further research is warranted to unravel the mechanistic pathways of these cells and to validate their prognostic value in larger, diverse patient cohorts.


  • Unveiling the multifaceted landscape of N-glycosylation in antibody variable domains: Insights and implications

    by Marcella Nunes Melo-Braga, Milene Barbosa Carvalho, Manuela Cristina Emiliano Ferreira, Jason Lavinder, Abdolrahim Abbasi, Giuseppe Palmisano, Morten Thaysen-Andersen, Mohammad M. Sajadi, Gregory C. Ippolito, Liza F. Felicori


  • Open Access

    Impact of murine breast tumor development in the kinetics of B cell subpopulations

    by Igor Visconte Gonçalves, Natália Pinheiro-Rosa, Lícia Torres, Mariana de Almeida Oliveira, Christiana da Silva Leite, José Miguel Ortega, Miriam Teresa Paz Lopes, Ana Maria Caetano Faria, Liza Figueiredo Felicori

    Despite presenting a worse prognosis and being associated with highly aggressive tumors, triple-negative breast cancer (TNBC) is characterized by the higher frequency of tumor-infiltrating lymphocytes, which have been implicated in better overall survival and response to therapy. Although in the last decades, the role and dynamics of tumor-infiltrating T cells have been extensively characterized, much less is known for B cells. Though recent studies have reported the capacity of B lymphocytes to recognize overly-expressed normal proteins, and tumor-associated antigens, how tumor development potentially modifies B cell response is yet to be elucidated. Our findings reveal distinct effects of 4T1 and E0771 murine tumor development on B cells in secondary lymphoid organs. Notably, we observe a significant expansion of total B cells and plasma cells in the tumor-draining lymph nodes (tDLNs) as early as 7 days after tumor challenge in both murine models, whereas changes in the spleen are less pronounced. Surprisingly, within the tumor microenvironment (TME) of both models, we detect distinct B cell subpopulations, but tumor development does not appear to cause major alterations in their frequency over time. Furthermore, our investigation into B cell regulatory phenotypes highlights that the B10 Breg phenotype remains unaffected in the evaluated tissues. However, we identified an increase in CD19 + LAG-3 + cells in tDLNs of both murine models. Interestingly, although CD19 + LAG-3 + cells represent a minor subset of total B cells (< 3%) in all evaluated tissues, most of these cells exhibit elevated expression of IgD, suggesting that LAG-3 may serve as an activation marker for B cells. In summary, our study demonstrates that TNBCs have a significant impact on the dynamics of B cells in secondary lymphoid organs, particularly in tDLNs. These findings suggest that TNBCs may influence the generation of antibodies and the immune response against tumor cells, shedding light on a relatively unexplored aspect of the immune microenvironment in TNBC.